CAXTON ASSOCIATES LP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$463,263
+166.1%
152,389
+187.9%
0.06%
+146.2%
Q2 2023$174,123
-62.8%
52,925
-21.8%
0.03%
-16.1%
Q4 2022$468,110
+9.4%
67,6460.0%0.03%
-45.6%
Q3 2022$428,000
-53.0%
67,646
-69.3%
0.06%
-36.0%
Q2 2022$911,000
+462.3%
220,154
+559.6%
0.09%
+584.6%
Q1 2022$162,000
-82.3%
33,376
-63.7%
0.01%
-86.0%
Q4 2021$917,00091,8200.09%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders